TMDX TransMedics Group PE ratio, current and historical analysis
As at Mar 12, 2025, the TMDX stock has a PE ratio of 62.69. This is based on the current EPS of $1.07 and the stock price of $67.08 per share.
TMDX PE ratio history
TransMedics Group PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 58.27 | N/A | $62.35 | $1.07 |
| 2023 | N/A | N/A | $78.93 | -$0.77 |
| 2022 | N/A | N/A | $61.72 | -$1.23 |
| 2021 | N/A | N/A | $19.16 | -$1.6 |
| 2020 | N/A | N/A | $19.9 | -$1.16 |
| 2019 | N/A | N/A | $18.59 | -$2.36 |
| 2018 | N/A | N/A | N/A | -$17.48 |
| 2017 | N/A | N/A | N/A | -$4.48 |
| 2016 | N/A | N/A | N/A | -$5.35 |
TransMedics Group PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 58.27 | -63.26% | $62.35 | $1.07 |
| Sep 2024 | 158.59 | -91.58% | $157 | $0.99 |
| Jun 2024 | 1,882.75 | N/A | $150.62 | $0.08 |
| Mar 2024 | N/A | N/A | $73.94 | -$0.32 |
| Dec 2023 | N/A | N/A | $78.93 | -$0.77 |
| Sep 2023 | N/A | N/A | $54.75 | -$1.09 |
| Jun 2023 | N/A | N/A | $83.98 | -$0.56 |
| Mar 2023 | N/A | N/A | $75.73 | -$0.94 |
| Dec 2022 | N/A | N/A | $61.72 | -$1.23 |
| Sep 2022 | N/A | N/A | $41.74 | -$1.5 |
| Jun 2022 | N/A | N/A | $31.45 | -$1.72 |
| Mar 2022 | N/A | N/A | $26.94 | -$1.7 |
| Dec 2021 | N/A | N/A | $19.16 | -$1.6 |
| Sep 2021 | N/A | N/A | $33.09 | -$1.37 |
| Jun 2021 | N/A | N/A | $33.18 | -$1.09 |
TMDX average PE ratio chart
TMDX PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| TMDX TransMedics Group Inc | 58.91 | $2.12B |
| OBIO Orchestra BioMed Holdings Inc | N/A | $151.29M |
| OM Outset Medical Inc | N/A | $28.37M |
Frequently asked questions
What is TransMedics Group's PE ratio?
As of Mar 12, 2025, TMDX stock has a price to earnings ratio of 62.69.
How is TMDX's PE ratio calculated (TransMedics Group PE ratio formula)?
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Mar 12, 2025), TransMedics Group's stock price is $67.08. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $1.07. Therefore, TransMedics Group's P/E ratio for today is 62.69. PE RATIO(62.69) = STOCK PRICE($67.08) / TTM EPS($1.07)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.